Integrating community pharmacy into community based anti-retroviral therapy program: A pilot implementation in Abuja, Nigeria
PublisherPublic Library of Science
MetadataShow full item record
AbstractBackground The landscape of Human Immunodeficiency Virus (HIV) epidemic control is shifting with the United Nations Programme on HIV/AIDS (UNAIDS) 90-90-90 benchmarks for epidemic control. Community-based Antiretroviral Therapy (CART) models have improved treatment uptake and demonstrated good clinical outcomes. We assessed the feasibility of integrating community pharmacy as a task shift structure for differentiated community ART in Abuja-Nigeria. Methods Stable patients on first line ART regimens from public health facilities were referred to community pharmacies in different locations within the Federal Capital Territory, Abuja for prescription refills and treatment maintenance. Bio-demographic and clinical data were collected from February 25, 2016 to May 31st, 2017 and descriptive statistics analysis applied. The outcomes of measure were prescription refill and patient retention in care at the community pharmacy. Results Almost 10% of stable patients on treatment were successfully devolved from eight health facilities to ten community pharmacies. Median age of the participants was 35 years [interquartile range (IQR); 30, 41] with married women in the majority. Prescription refill was 100% and almost all the participants (99.3%) were retained in care after they were devolved to the community pharmacies. Only one participant was lost-to-follow-up as a result of death. Conclusion Excellent prescription refill and high retention in care with very low loss-to-follow-up were associated with the community pharmacy model. The use of community pharmacy for community ART is feasible in Nigeria. We recommend the scale up of the model in all the 36 states of Nigeria. Copyright 2018 Avong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85040312153&doi=10.1371%2fjournal.pone.0190286&partnerID=40&md5=27dbbff8b382bc9b1501dd07e510522b; http://hdl.handle.net/10713/9389
- Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
- Authors: Hirsch JD, Rosenquist A, Best BM, Miller TA, Gilmer TP
- Issue date: 2009 Jan-Feb
- Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
- Authors: Hirsch JD, Gonzales M, Rosenquist A, Miller TA, Gilmer TP, Best BM
- Issue date: 2011 Apr
- High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
- Authors: Agolory SG, Auld AF, Odafe S, Shiraishi RW, Dokubo EK, Swaminathan M, Dalhatu I, Onotu D, Abiri O, Debem H, Bashorun A, Ellerbrock TV
- Issue date: 2017
- Factors before enrolment are associated with being removed from a Pharmacy-only Refill Programme at a large urban HIV/AIDS clinic, Uganda.
- Authors: Nakiwogga-Muwanga A, Katabira E, Kiragga A, Kambugu A, Nakibuuka-Lubwama E, Manabe YC, Alamo ST, Colebunders R
- Issue date: 2014 Feb
- Which adherence measure - self-report, clinician recorded or pharmacy refill - is best able to predict detectable viral load in a public ART programme without routine plasma viral load monitoring?
- Authors: Mekuria LA, Prins JM, Yalew AW, Sprangers MA, Nieuwkerk PT
- Issue date: 2016 Jul